|
Market Closed -
Nasdaq
00:00:00 21/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 807.48 USD | +3.25% |
|
+7.22% | +4.61% |
| 10-20 | AstraZeneca-Amgen asthma drug hits 69% remission in esophageal disease trial | RE |
| 10-19 | Major drugmakers turn to China for licensing deals | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.25% | +7.22% | +2.88% | +20.13% | +4.61% | +40.00% | -0.12% | +43.50% | +117.51% | 80.63B | |
| +3.49% | +10.04% | +11.34% | +11.92% | +19.45% | +58.68% | +119.56% | +426.69% | +1,530.25% | 1,144B | |
| +2.19% | +4.32% | -3.94% | +4.24% | +25.32% | +33.88% | +69.52% | +58.36% | +125.79% | 625B | |
| +2.26% | +5.37% | +9.52% | +14.09% | +26.52% | +24.57% | +97.69% | +166.65% | +368.07% | 511B | |
| +2.58% | +8.37% | +9.28% | +17.55% | +18.80% | +38.71% | +63.14% | +10.70% | +67.70% | 377B | |
| +3.25% | +4.45% | +0.97% | +19.21% | +40.89% | +71.80% | +44.44% | +82.93% | +139.50% | 366B | |
| +1.85% | +6.04% | +9.90% | +2.76% | +15.42% | +21.47% | +49.17% | +62.76% | +68.22% | 291B | |
| +1.76% | +6.07% | +0.94% | +1.92% | -8.50% | +0.43% | +20.98% | +43.91% | +153.50% | 262B | |
| +3.29% | +6.32% | +13.82% | +20.53% | +34.11% | +44.71% | +57.43% | +109.36% | +171.79% | 237B | |
| +2.25% | +5.81% | +4.26% | +17.49% | +27.51% | +27.13% | +101.17% | +134.09% | +110.62% | 194B | |
| +1.83% | +1.77% | -7.23% | -20.37% | -19.69% | -27.40% | -61.46% | -21.64% | +87.78% | 174B | |
| +2.28% | +6.13% | +8.86% | +21.66% | +20.92% | +21.95% | -1.76% | -29.65% | -7.47% | 172B | |
| +2.53% | +6.07% | +1.24% | +7.11% | +13.52% | +22.80% | +42.22% | +177.45% | +520.66% | 130B | |
| +4.84% | +8.84% | -2.19% | +2.53% | +14.35% | +41.50% | +9.25% | +6.22% | +22.48% | 126B | |
| +1.95% | +7.09% | +17.78% | +23.89% | +25.58% | +30.76% | +127.49% | +399.84% | +536.07% | 120B | |
| +0.73% | +6.59% | -0.48% | -0.72% | +2.41% | +14.39% | +27.80% | +6.15% | -10.25% | 100B | |
| +3.62% | +4.01% | -0.63% | -4.33% | -11.05% | -15.02% | -25.55% | -12.85% | +6.02% | 99.04B | |
| +6.69% | +11.94% | +57.15% | +306.93% | +720.89% | +788.69% | +201.09% | -27.31% | - | 96.65B | |
| +1.42% | +6.40% | +12.75% | +8.48% | +19.41% | +29.61% | -1.61% | -26.08% | +47.51% | 71.51B | |
| +1.26% | +7.80% | -2.09% | -11.98% | -21.01% | -9.04% | +44.08% | +67.94% | +449.45% | 66.89B | |
| Average | +1.79% | +5.36% | +7.21% | +23.15% | +48.47% | +62.98% | +49.23% | +83.95% | +237.12% | 262.23B | |
| Weighted average by Cap. | +1.46% | +4.99% | +6.71% | +15.56% | +31.53% | +48.78% | +68.04% | +151.01% | +467.77% |
- Stock Market
- Stocks
- REGN Stock
- Sector Regeneron Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
